VALEANT PHARMACEUTICALS INTL

VRX stock holders 13F

5 superinvestors reported owning VRX (Common Stock) according to the gurus' 2016 Q2 reports.

Top 5 gurus who own (VRX) VALEANT PHARMACEUTICALS INTL

The 5 super investors (holders) owning VRX (by the percentage (%) of portfolio) are Francis Chou - Chou Associates Management (11.33%), Bill Ackman - Pershing Square Capital Management (5.79%), Jeffrey Ubben - ValueAct Holdings (2.74%), Bill Miller - Miller Value Partners (2.61%) and Ravenel Boykin Curry IV - Eagle Capital Management (0.00%) as of their 2016 Q2 reports.

To check the latest activities of the top VRX shareholders between value investors, please click on the "Activity" tab.

To see the historical data of VRX's holders please click on the "2016 Q2" dropdown menu and select the date.

# of holders: 5
Period: 2016 Q2
Type: Common Stock
History
Name
Company
% of
Portfolio
Shares*
Price*
Value
% (shares)
Activity
% change to
Portfolio
Bill Ackman
Pershing Square Capital Management
5.79%
21,591,122
$20.14
$434,845,000
Bill Miller
Miller Value Partners
2.61%
2,006,300
$20.14
$40,407,000
+26.90% (+425,350)
+0.55%
Francis Chou
Chou Associates Management
11.33%
1,446,843
$20.14
$29,139,000
+48.11% (+470,000)
+3.68%
Jeffrey Ubben
ValueAct Holdings
2.74%
14,994,261
$20.14
$301,984,000
Ravenel Boykin Curry IV
Eagle Capital Management
0.00%
31,253
$20.13
$629,000
-99.47% (-5,867,292)
-0.51%
AVG reported hold price*: $20.14

Completely sold out

History
Name
Company
Sold
Shares*
% change to
Portfolio
Glenn Greenberg
Brave Warrior Advisors
2,034,281
-2.99%
David Tepper
Appaloosa Management
902,475
-0.65%

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.